| Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey A Versporten, P Zarb, I Caniaux, MF Gros, N Drapier, M Miller, V Jarlier, ... The Lancet Global Health 6 (6), e619-e629, 2018 | 572 | 2018 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 547 | 2022 |
| Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 265 | 2019 |
| Clinical and economic impact of contaminated blood cultures within the hospital setting YM Alahmadi, MA Aldeyab, JC McElnay, MG Scott, FWD Elhajji, ... Journal of Hospital Infection 77 (3), 233-236, 2011 | 247 | 2011 |
| Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series … MA Aldeyab, DL Monnet, JM López-Lozano, CM Hughes, MG Scott, ... Journal of Antimicrobial Chemotherapy 62 (3), 593-600, 2008 | 201 | 2008 |
| An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in … MA Aldeyab, MP Kearney, MG Scott, MA Aldiab, YM Alahmadi, ... Journal of antimicrobial chemotherapy 67 (12), 2988-2996, 2012 | 181 | 2012 |
| The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide GH Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V, ... Pediatr Infect Dis J. 32 (6), e242-53., 2013 | 171 | 2013 |
| The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis T Mestrovic, GR Aguilar, LR Swetschinski, KS Ikuta, AP Gray, ND Weaver, ... The Lancet Public Health 7 (11), e897-e913, 2022 | 144 | 2022 |
| The impact of antibiotic use on the incidence and resistance pattern of extended‐spectrum beta‐lactamase‐producing bacteria in primary and secondary healthcare settings MA Aldeyab, S Harbarth, N Vernaz, MP Kearney, MG Scott, ... British journal of clinical pharmacology 74 (1), 171-179, 2012 | 131 | 2012 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 101 | 2022 |
| Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study H Omeish, A Najadat, S Al-Azzam, N Tarabin, A Abu Hameed, ... Human vaccines & immunotherapeutics 18 (1), 1981086, 2022 | 99 | 2022 |
| Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019 B Armocida, L Monasta, S Sawyer, F Bustreo, G Segafredo, ... The Lancet Child & Adolescent Health 6 (6), 367-383, 2022 | 82 | 2022 |
| Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): Results from a worldwide point prevalence … I Pauwels, A Versporten, N Drapier, E Vlieghe, H Goossens Journal of Antimicrobial Chemotherapy 76 (6), 1614-1624, 2021 | 79 | 2021 |
| A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use MA Aldeyab, MP Kearney, JC McElnay, FA Magee, G Conlon, D Gill, ... British journal of clinical pharmacology 71 (2), 293-296, 2011 | 74 | 2011 |
| A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance JM López-Lozano, T Lawes, C Nebot, A Beyaert, X Bertrand, D Hocquet, ... Nature Microbiology 4 (7), 1160-1172, 2019 | 72 | 2019 |
| Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures MA Aldeyab, MJ Devine, P Flanagan, M Mannion, A Craig, MG Scott, ... Infection Control & Hospital Epidemiology 32 (3), 210-219, 2011 | 62 | 2011 |
| Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated … MA Aldeyab, S Harbarth, N Vernaz, MP Kearney, MG Scott, C Funston, ... Antimicrobial agents and chemotherapy 53 (5), 2082-2088, 2009 | 62 | 2009 |
| Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis AMA Khan S, Hasan SS, Bond SE, Conway BR xpert Rev Anti Infect Ther., 1-24, 2021 | 59* | 2021 |
| Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study MR Khdour, HO Hallak, MA Aldeyab, MA Nasif, AM Khalili, AA Dallashi, ... British journal of clinical pharmacology 84 (4), 708-715, 2018 | 54 | 2018 |
| Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan Z Ul Mustafa, M Salman, M Aldeyab, CS Kow, SS Hasan SN comprehensive clinical medicine 3 (8), 1691-1695, 2021 | 47 | 2021 |
